PODD
Insulet Corporation
$138.97
-4.66%
2026-06-22
About Insulet Corporation
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager with a color touch screen user interface; and the Omnipod Insulin Management System. It also provides pods for Amgen for use in the Neulasta Onpro kit, which is a delivery system to help reduce the risk of infection after intense chemotherapy. The company sells its products to end-users through the pharmacy channel; and independent distributors. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
Key Fundamentals
P/E Ratio
37.30
Forward P/E
19.78
EPS (TTM)
$4.28
ROE
23.0%
Revenue Growth (YoY)
33.9%
Profit Margin
10.4%
Debt/Equity
77.98
Price/Book
7.42
Beta
1.20
Market Cap
$11.06B
Avg Volume (10D)
2.1M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$221.11
60D Low
$138.79
Avg Volume
1.4M
Latest Close
$138.97
Get breakout alerts for PODD
Sign up for Breakout Scanner to receive daily notifications when PODD triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Insulet Corporation (PODD) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors PODD daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. PODD operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.